Amgen Receives Positive CHMP Opinion For ABP 501 Biosimilar Adalimumab For...
THOUSAND OAKS Calif. Jan. 27 2017 PRNewswire Amgen NASDAQAMGN today announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has adopted a positive...
View ArticleEuropean IBD specialists support switching to biosimilars
The European Crohns and Colitis Organization ECCO has published results of a consensus meeting held on 15 October 2016 in Vienna Austria in which they support switching from reference infliximab to...
View ArticleCHMP backs Pfizer's Xeljanz Amgen's biosimilar Humira
On Friday EMA's CHMP backed approval of several therapies including Xeljanz tofacitinib from Pfizer Inc. NYSEPFE and ABP 501 from Amgen Inc. NASDAQAMGN a biosimilar of Humira
View ArticleAbbVie Inc ABBV Pharmaceuticals Healthcare Deals and Alliances Profile Prices...
SummaryAbbVie Inc AbbVie is a researchbased biopharmaceutical company that carries out the research development manufacture and commercialization of advanced therapies to treat complex and serious...
View ArticleDeciphera Pharmaceuticals LLC Pharmaceuticals Healthcare Deals and Alliances...
SummaryDeciphera Pharmaceuticals LLC Deciphera Pharmaceuticals is a drug research and development company that develops designs and commercializes kinase inhibiting drugs for treating immunological...
View ArticleCelltrion Inc 068270 Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryCelltrion Inc Celltrion is a biopharmaceutical company that focuses on research development and manufacture of biosimilars and novel biopharmaceuticals. The company offers monoclonal antibodies...
View ArticleMRC Technology appoints Steve Visscher as new trustee
London UK 30 January 2017 MRC Technology an independent life science medical research charity has appointed Steve Visscher CBE currently BBSRC Deputy Chief Executive – International to its...
View ArticleNew Model Differentiates Intestinal Tuberculosis From Crohn's Disease
A new model based on metaanalyses of 55 distinct predictors accurately differentiates intestinal tuberculosis ITB from Crohn's disease CD. Reuters Health Information
View ArticlePharmacyChecker.com Adds Patient Assistance Program Information Expanding...
PharmacyChecker.com adds information on nocost and lowcost patient assistance programs offered by drug companies to eligible patients in the U.S.White Plains NY PRWEB February 01 2017 Expanding on its...
View ArticleProtagonist Therapeutics to Participate in the Leerink Partners 6th Annual...
MILPITAS Calif. Feb. 1 2017 PRNewswire Protagonist Therapeutics Inc. NASDAQ PTGX will participate in the Leerink Partners 6th Annual Global Healthcare Conference on February 16 at Lotte New York Palace...
View ArticleLarge Finnish genetic study uncovers potential new treatments for...
Researchers from the Research Centre of Applied and Preventive Cardiovascular Medicine at the University of Turku Finland have studied over ten million DNA variations and found new links between the...
View ArticleGenetic study uncovers potential new treatments for inflammatory diseases
Researchers have studied over ten million DNA variations and found new links between the human genome and inflammation tracers. The study uncovered new possibilities for treatment of diseases such as...
View ArticleSoligenix Announces SGX301 Receives Promising Innovative Medicine Designation...
PRINCETON N.J. Feb. 2 2017 PRNewswire Soligenix Inc. Nasdaq SNGX Soligenix or the Company a latestage biopharmaceutical company focused on developing and commercializing products to treat rare diseases...
View ArticleWhat's Your Gut Wellness Score Thryve Launches With New Microbiome Testing...
SAN FRANCISCO Feb. 2 2017 PRNewswire Thryve providers of high quality microbiotics and microbiome testing launches the nation's first monthly microbiome testing and probiotics subscription. The...
View ArticleTaiwanJ Pharmaceuticals Co Ltd 6549 Pharmaceuticals Healthcare Deals and...
SummaryTaiwanJ Pharmaceuticals Co Ltd TaiwanJ is a pharmaceutical company that develops and commercialize firstinclass small molecules as TLR4 tolllike receptor 4 antagonists. TLR4 is a transmembrane...
View ArticleExclusive Enteral Feeding May Help Some Crohn's Patients Avoid Surgery
Exclusive enteral nutrition EEN may help avoid surgery in some Crohn's disease CD patients presenting with strictures or penetrating complications new research shows. Reuters Health Information
View ArticleAmgen Reports Fourth Quarter And Full Year 2016 Financial Results
THOUSAND OAKS Calif. Feb. 2 2017 PRNewswire Amgen NASDAQAMGN today announced financial results for the fourth quarter and full year of 2016. Key results include For the fourth quarter total revenues...
View ArticleGlobal Gastrointestinal Endoscopy Devices Market 20162020 Prices from USD $2500
About Gastrointestinal Endoscopy DevicesThe endoscopes used to inspect the internal lining of the GI tract are known as GI endoscopic devices. The diagnosis of GI tract includes large intestine stomach...
View ArticleMarker Predicts IBD in Spine Disease CMECE
MedPage Today Elevated fecal calprotectin linked with later Crohn's in ankylosing spondylitis
View Article